Provided by Tiger Fintech (Singapore) Pte. Ltd.

Phio Pharmaceuticals

2.96
+0.500020.33%
Post-market: 2.990.0300+1.01%19:52 EDT
Volume:2.07M
Turnover:6.11M
Market Cap:14.14M
PE:-0.31
High:3.19
Open:2.54
Low:2.53
Close:2.46
Loading ...

Phio Pharmaceuticals Announces Publication in Clinical, Cosmetic and Investigational Dermatology

Newsfile
·
02 Jan

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Newsfile
·
24 Dec 2024

Investors Look to Reverse Last Week's Slide as US Futures Mixed Monday Pre-Bell

MT Newswires Live
·
23 Dec 2024

Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket

Benzinga
·
23 Dec 2024

Phio Pharmaceuticals Announces $1.15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Newsfile
·
20 Dec 2024

BRIEF-Phio Pharmaceuticals Positive Safety Monitoring Committee Recommendation To Continue To Third Dose Cohort In Its Clinical Study Of Ph-762

Reuters
·
19 Dec 2024

Phio Pharmaceuticals: Positive Safety Monitoring Committee Recommendation to Continue to Third Dose Cohort in Its Clinical Study of Ph-762

THOMSON REUTERS
·
19 Dec 2024

Phio Pharmaceuticals Corp: Intratumoral Injections Have Been Well Tolerated

THOMSON REUTERS
·
19 Dec 2024

Phio Pharmaceuticals Corp: No Dose-Limiting Toxicities, or Serious Adverse Events in Participants Receiving Intratumoral Ph-762

THOMSON REUTERS
·
19 Dec 2024

Phio Pharmaceuticals Safety Panel Approves Dose Escalation in Skin Cancer Trial

MT Newswires Live
·
19 Dec 2024

Phio Pharmaceuticals Announces Positive Safety Monitoring Committee (SMC) Recommendation to Continue to Third Dose Cohort in its Clinical Study of PH-762

Newsfile
·
19 Dec 2024

Phio Pharmaceuticals Announces Publication in Frontiers in Immunology

Newsfile
·
12 Dec 2024

Phio Pharmaceuticals is a Finalist for the Technology Disruptor of the Year Award

Newsfile
·
10 Dec 2024